The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Self-stigma was associated with higher dropout rates, engagement, and weight loss among individuals who completed a weight loss program.
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...